(Q34764834)

4 August 2017

title

Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature (English)

1 reference

4 August 2017

1 reference

1 reference

4

Georges Kaltenbach

0 references

author name string

Emmanuel Andrès

1

1 reference

4 August 2017

Frédéric Maloisel

2

1 reference

4 August 2017

Jean Emmanuel Kurtz

3

1 reference

4 August 2017

Martine Alt

5

1 reference

4 August 2017

Jean Christophe Weber

6

1 reference

4 August 2017

Jean Sibilia

7

1 reference

4 August 2017

Jean Louis Schlienger

8

1 reference

4 August 2017

Jean Frédéric Blicklé

9

1 reference

4 August 2017

Jean Marie Brogard

10

1 reference

4 August 2017

Patrick Dufour

11

1 reference

4 August 2017

publication date

1 August 2002

1 reference

European Journal of Internal Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

324-328

1 reference

[Acute drug-induced agranulocytosis. Clinical study apropos of 30 patients and evolution of etiologies over 2 decades]

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Drug-induced agranulocytosis: prognostic factors in a series of 168 episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Drug-induced agranulocytosis in older people. A case series of 25 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

[Do hematopoietic growth factors have a role in the treatment of drug-induced agranulocytosis?]

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Haematopoietic growth factor in antithyroid-drug-induced agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Drug-associated agranulocytosis: experience at Strasbourg Teaching Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

A population-based case-cohort study of drug-associated agranulocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Drug-associated agranulocytosis: 20 years of reporting in The Netherlands (1974-1994).

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Nonchemotherapy drug-induced agranulocytosis: a review of 118 patients treated with colony-stimulating factors

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2802%2900085-7

7 January 2021

10.1016/S0953-6205(02)00085-7

Identifiers

DOI

1 reference

4 August 2017

1 reference